Surgical options for lymphedema after gynecological cancer treatment: current trends and advances.

Int J Gynecol Cancer

MD Anderson Department of Plastic Surgery, Houston, Texas, USA.

Published: March 2024

Lower leg lymphedema is an important complication after gynecological treatment that can severely affect the quality of life of long-term survivors of these malignancies. As a chronic and progressive disease, affected patients will require life-long therapy centered on compression. Although conventional compressive treatments can be effective, they are extremely burdensome and time-consuming for most patients and adherence is challenging. With advances in the field of reconstructive microsurgery, new procedures have been developed in the past decades to help these patients in their continuous care and have been offered at many oncological centers around the world as a first line of treatment. We performed a PubMed search using the Mesh terms 'Lymphedema/surgery' and 'Lower extremity' yielding a total of 508 articles. Of these, 35 articles were included for analysis. Articles that failed to provide a comprehensive analysis of outcomes following surgical treatment, studies examining treatment for upper limb lymphedema, primary lymphedema, or lower extremity lymphedema resulting from non-gynecologic etiologies, and studies that failed to have a minimum of 6 months follow-up were excluded. A comprehensive review of these 35 articles including over 1200 patients demonstrated large variability on the outcomes reported; however, an overall benefit from these procedures was found. Surgical options including lymphovenous anastomosis, vascularized lymph node transfers, and excisional procedures can be performed in patients with lower leg lymphedema, depending on staging and findings in indocyanine green lymphography. Surgical treatment of lymphedema is an effective option that can improve symptoms and quality of life of patients suffering from lymphedema following gynecologic cancers.

Download full-text PDF

Source
http://dx.doi.org/10.1136/ijgc-2023-004607DOI Listing

Publication Analysis

Top Keywords

surgical options
8
lymphedema
8
lower leg
8
leg lymphedema
8
quality life
8
surgical treatment
8
treatment
6
patients
6
surgical
4
options lymphedema
4

Similar Publications

Tumor-induced osteomalacia (TIO) is a rare paraneoplastic syndrome caused by hypersecretion of fibroblast growth factor 23 (FGF23) by typically benign phosphaturic mesenchymal tumors (PMTs). FGF23 excess causes chronic hypophosphatemia through renal phosphate losses and decreased production of 1,25-dihydroxy-vitamin-D. TIO presents with symptoms of chronic hypophosphatemia including fatigue, bone pain, weakness, and fractures.

View Article and Find Full Text PDF

Introduction: Traumatic injuries are a significant public health concern globally, resulting in substantial mortality, hospitalisation and healthcare burden. Despite the establishment of specialised trauma centres, there remains considerable variability in trauma-care practices and outcomes, particularly in the initial phase of trauma resuscitation in the trauma bay. This stage is prone to preventable errors leading to adverse events (AEs) that can impact patient outcomes.

View Article and Find Full Text PDF

Carcinoma of unknown primary (CUP) comprises 2-5% of cancer diagnoses worldwide, with a prevalence that has modestly declined with increased availability of advanced diagnostic tools such as next-generation sequencing (NGS). This case presentation illustrates the possibilities and gaps that remain with improving diagnostic capabilities in identifying and effectively treating CUP. This is the case of a rapidly enlarging right axillary mass without a primary tumour site and histological evaluation demonstrating a poorly differentiated neoplasm.

View Article and Find Full Text PDF

Systemic siliconomas following breast implant rupture.

BMJ Case Rep

January 2025

General Surgery, Universidade de Lisboa Faculdade de Medicina, Lisboa, Portugal.

We report a case of a woman in her late 40s with a history of breast implant surgery following breast cancer treatment. She presented with asymmetrical breast enlargement, palpable contralateral axillary lymph nodes and cutaneous nodules on both forearms. In addition, imaging evaluation revealed intracapsular implant rupture, ipsilateral internal mammary enlarged lymph nodes and multiple mediastinal lymphadenopathies.

View Article and Find Full Text PDF

Evaluation and Management of the External Nasal Valve.

Otolaryngol Clin North Am

January 2025

Department of Otolaryngology-Head and Neck Surgery, Division of Facial Plastic and Reconstructive Surgery, Henry Ford Hospital, 2799 West Grand Boulevard K-8, Detroit, MI 48202, USA; Department of Surgery, Michigan State University, 4660 South Hagadorn Road, Suite #620, East Lansing, MI 48823, USA; Wayne State University School of Medicine, 540 East Canfield Street, Detroit, MI 48201, USA.

The external nasal valve is the anatomic structure formed by the caudal septum, alar rim, medial crura of the lower lateral cartilage, and nasal sill at the level of the nasal vestibule. Evaluation of external nasal valve dysfunction is dependent upon a thorough history and physical examination. Symptoms and quality of life impact are the main drivers for patients to seek out clinical evaluation.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!